A Synthetic Lethality–Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1

These results offer a rationale for an epigenetic-based treatment of many lung cancers and other common cancers lacking known therapeutic gene mutations, providing a broad catchment strategy for treatment.